A subsequent evaluation across multiple bulk datasets comprised 241 conventional adenomas and 598 primary CRCs at various disease stages that consistently showed increased TGFβ-dependent stromal activation during malignant transformation and tumor progression, which was particularly evident during the transition of from conventional adenoma to carcinoma. The gene discussed is TGFB1; the disease is neoplasm.